Better Functional Mobility in Community-dwelling Elderly is Related to D-hormone Serum Levels and to Daily Calcium Intake
Overview
Nutritional Sciences
Authors
Affiliations
The influence of calcitropic hormones on functional mobility has been studied in vitamin D (calcidiol) deficient elderly or elderly with a history of falls, however, data in community-dwelling independent vitamin D replete elderly are missing. We therefore assessed in an observational survey the association of calcidiol (25(OH)D3) and calcitriol (D-hormone / 1,25(OH)2D3) status as well as of daily calcium intake on functional mobility in older subjects We evaluated 192 women and 188 men, aged superior 70 years and living independently. Average Timed-up and go test (TUG-test) in seconds was taken as measure of functional mobility. Calcidiol and D-hormone serum concentrations and daily calcium intake were studied in multivariate controlled linear regression models with TUG-test performance as the dependent variable and/or as dichotomous variables (deficient vs. non-deficient, above vs. below the median, respectively). Subjects with low D-hormone serum concentrations took significantly more time to perform the TUG-test (low = 7.70s +/- 2.52 SD ; high = 6.70s +/- 1.29 SD; p = 0.004). In the linear multivariate controlled regression model increased D-hormone serum concentrations predicted better TUG-test performance (estimate -0.0007, p = 0.044). Participants with a calcium intake of > or =512 mg/day were significantly faster to perform the TUG-test than participants with a daily calcium intake of <512 mg/day (estimate:-0.43, p = 0.007). Other significant predictors of better TUG-test performance in both models were: male gender, less comorbid conditions, younger age, lower BMI, iPTH serum levels and creatinine clearance. Calcidiol serum levels were not associated with TUG-test performance. Higher D-hormone status and a calcium intake of > or =512 mg/day in community-dwelling independent older persons are significant determinants of better functional mobility. Therefore, to ensure optimal functional mobility, the care of older persons should address correction of D-hormone deficiency and increasing daily calcium intake.
Kang T, Hong J, Radnaabaatar M, Park S, Jung J BMJ Open. 2021; 11(6):e047000.
PMID: 34117046 PMC: 8202114. DOI: 10.1136/bmjopen-2020-047000.
Endocrine determinants of incident sarcopenia in middle-aged and elderly European men.
Gielen E, ONeill T, Pye S, Adams J, Wu F, Laurent M J Cachexia Sarcopenia Muscle. 2015; 6(3):242-52.
PMID: 26401471 PMC: 4575556. DOI: 10.1002/jcsm.12030.
Abboskhujaeva L, Ismailov S, Alikhanova N Drugs R D. 2014; 14(4):315-24.
PMID: 25480348 PMC: 4269821. DOI: 10.1007/s40268-014-0069-1.
Dupuy C, Lauwers-Cances V, Abellan van Kan G, Gillette S, Schott A, Beauchet O J Nutr Health Aging. 2013; 17(2):119-24.
PMID: 23364488 DOI: 10.1007/s12603-012-0089-x.
Gordon P, Doyle J, Johansen K J Ren Nutr. 2012; 22(4):423-33.
PMID: 22227183 PMC: 4815913. DOI: 10.1053/j.jrn.2011.10.006.